View of Real-Time Quantitative PCR: Appli- 2966 Journal of the American Society of Nephrology J Am Soc Nephrol 14: 2958–2966, 2003
Total Page:16
File Type:pdf, Size:1020Kb
J Am Soc Nephrol 14: 2958–2966, 2003 Gene Expression Profiles of Podocyte-Associated Molecules as Diagnostic Markers in Acquired Proteinuric Diseases HOLGER SCHMID,* ANNA HENGER,* CLEMENS D. COHEN,* KARIN FRACH,* HERMANN-JOSEF GRO¨ NE,† DETLEF SCHLO¨ NDORFF,* and MATTHIAS KRETZLER* *Medizinische Poliklinik, Ludwig-Maximilians-University of Munich, Munich, Germany; and †German Cancer Research Center, Department of Cellular and Molecular Pathology, Heidelberg, Germany Abstract. For identifying potential diagnostic markers of pro- analyzed glomeruli, whereas podocin mRNA expression did teinuric glomerulopathies, glomerular mRNA levels of mole- not correlate. Because varying amounts of housekeeper cDNA cules relevant for podocyte function (␣-actinin-4, glomerular per glomerulus can confound expression ratios relevant for a epithelial protein 1, Wilms tumor antigen 1, synaptopodin, subpopulation of cells, an “in silico” microdissection was dystroglycan, nephrin, podoplanin, and podocin) were deter- performed using a podocyte-specific cDNA as a reference mined by quantitative real-time RT-PCR from microdissected gene. Expression ratio of podocin to synaptopodin, the two glomeruli. Biopsies from 83 patients with acquired proteinuric genes with the most disparate expression, allowed a robust diseases were analyzed (minimal change disease [MCD; n ϭ separation of FSGS from MCD and nephrosclerosis. Segrega- 13], benign nephrosclerosis [n ϭ 16], membranous glomeru- tion of FSGS from MCD via this ratio was confirmed in an lopathy [n ϭ 31], focal and segmental glomerulosclerosis independent population of formaldehyde-fixed archival biop- [FSGS; n ϭ 9], and controls [n ϭ 14]). Gene expression levels sies (MCD, n ϭ 5; FSGS, n ϭ 4) after glomerular laser capture normalized to two different housekeeping transcripts (glycer- microdissection. In addition, the expression marker was able to aldehyde-3-phosphate-dehydrogenase and 18 S rRNA) did not predict steroid responsiveness in diagnostically challenging allow a separation between proteinuric disease categories. cases of MCD versus FSGS (n ϭ 6). As the above approach However, a significant positive correlation between ␣-acti- can be performed as an add-on diagnostic tool, these molecular nin-4, glomerular epithelial protein 1, synaptopodin, dystrogly- diagnostic parameters could give novel information for the can, Wilms tumor antigen 1, and nephrin was found in all management of proteinuric diseases. Proteinuric glomerular diseases still pose a formidable chal- Finnish type, has been localized to the podocyte slit diaphragm lenge to nephrology. Recent studies have highlighted the im- (6). Mutations in a gene termed NPHS2, encoding the novel portance of proteinuria both as a clinical prognostic marker and protein podocin, are associated with an autosomal-recessive as a factor predicting progressive loss of renal function (1–3). familial steroid-resistant nephrotic syndrome (7). Mutations in Alteration of the glomerular filtration barrier leads via damage the gene for ␣-actinin-4 (ACTN4) have been identified by of the glomerular podocyte to leakage of proteins into the Kaplan et al. (8) to be causative in an autosomal-dominant ultrafiltrate (4). The filtration barrier consists of a specialized form of familial focal and segmental glomerulosclerosis fenestrated endothelium, the fibrillar, hydrated meshwork of (FSGS). Thus mutations of various podocyte-specific genes in the glomerular basement membrane (GBM), and interdigitat- hereditary proteinuric diseases have identified novel compo- ing podocyte foot processes with intervening filtration slits as nents of the glomerular filtration barrier. the final filtration barrier (5). Identification of mutations in Gene expression analysis of the aforementioned molecules podocyte-associated molecules in various hereditary nephrotic might elucidate common or distinct regulatory pathways in disorders has highlighted the key role of the podocyte for the nonhereditary proteinuria and provide valuable diagnostic and pathophysiology of proteinuria. The gene product of NPHS1, prognostic information. This additional diagnostic information nephrin, mutated in congenital nephrotic syndrome of the could be of particular relevance, as proteinuric diseases not only have a highly variable cause but also follow distinctly different clinical courses. Furthermore, similar clinical presen- Received January 24, 2003. Accepted July 19, 2003. tation, lack of specific clinical or laboratory parameters, and Correspondence to Dr. Matthias Kretzler, Medizinische Poliklinik, Ludwig- histologically indistinguishable lesions can complicate the di- Maximilians-Universität München, Pettenkoferstrasse 8a, D-80336, Munich, Germany. Phone: 49-89-5996845; Fax: 49-89-5996860; E-mail: kretzler@ agnostic process (9) and the clinical management of the glo- medpoli.med.uni-muenchen.de merulopathies. For example, minimal change glomerulopathy 1046-6673/1411-2958 (MCD), although often protracted, does not lead to terminal Journal of the American Society of Nephrology renal failure, whereas FSGS, if not controlled by aggressive Copyright © 2003 by the American Society of Nephrology therapy, frequently progresses to ESRD. DOI: 10.1097/01.ASN.0000090745.85482.06 The present study focuses on the glomerular mRNA expres- J Am Soc Nephrol 14: 2958–2966, 2003 Gene Expression Profiles of Podocyte-Associated Molecules in Proteinuric Diseases 2959 sion of a comprehensive series of podocyte-associated mole- Microdissection, LCM, and RNA Isolation cules in a large number of renal biopsies from adult patients For a detailed description of the protocol used, see reference 10. In with acquired proteinuric glomerulopathies. mRNA expression brief, cortical tissue segments were manually microdissected in glo- of the podocyte markers ACTN4, Glomerular epithelial protein meruli and tubulointerstitial compartments. Glomerular microdissec- 1 (GLEPP-1), Wilms tumor antigen 1 (WT-1), synaptopodin, tion was confirmed by detection of the glomerulus-specific cDNA for dystroglycan, nephrin, podoplanin, and podocin was evaluated WT-1. Total RNA was isolated from the microdissected glomeruli by real-time RT-PCR on RNA isolated from microdissected using a commercially available silica gel–based isolation protocol (RNeasy-Mini; Qiagen, Hilden, Germany) followed by random glomeruli. A systematic analysis of the relationship between primed reverse transcription. For confirmation experiments on form- the expression levels revealed a stringent positive correlation aldehyde-fixed archival renal tissues, glomeruli were microdissected of most podocyte-specific cDNA. From the expression data, a by a laser beam and harvested by laser pressure catapulting (PALM marker set could be extracted, allowing a robust separation of Laser Micro Beam System; P.A.L.M, Wolfratshausen, Germany), and the histologic entities FSGS from MCD and benign nephro- total RNA was isolated as described in detail (11). sclerosis (NS). These findings could be confirmed in formal- dehyde-fixed archival renal tissues after laser capture micro- dissection (LCM), making routine clinical application Real-Time RT-PCR technically feasible. Real-time RT-PCR was performed on a TaqMan ABI 7700 Se- quence Detection System (Applied Biosystems, Weiterstadt, Ger- many) using heat-activated TaqDNA polymerase (Amplitaq Gold; Material and Methods Applied Biosystems). After an initial hold of 2 min at 50°C and 10 Kidney Biopsies: Patients and Control Groups min at 95°C, the samples were cycled 40 times at 95°C for 15 s and Human kidney biopsies from a total of 83 patients, obtained in a 60°C for 60 s. Target gene forward and reverse primers and probes multicenter study for gene expression analysis in renal biopsies (the were designed using Primer Express 1.5 software (Applied Biosys- European Renal cDNA Consortium; see appendix for participating tems, Foster City, CA). Commercially available predeveloped Taq- centers) were included. From diagnostic renal biopsies, a segment not Man assay reagents were used for the internal standards human required for diagnostic evaluation was processed for gene expression glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) and 18 S ribo- analysis after informed consent was obtained according to the guide- somal RNA (18 S rRNA). All primers and probes were obtained from lines of the respective local ethical committees. Applied Biosystems. The primers for GAPDH, ACTN4, GLEPP-1, Microdissected glomeruli from 69 patients with five different pro- WT-1, synaptopodin, dystroglycan, nephrin (NPHS1), podoplanin, teinuric diseases and 14 control subjects were analyzed. Patients were and podocin (NPHS2) were cDNA-specific, not amplifying genomic stratified according to their histologic diagnosis by the reference DNA. The following sequences of oligonucleotide primers (300 nM) pathologist of the European Renal cDNA Consortium into the follow- and probes (100 nM) were used: ACTN4: sense GAGGCCCAGAG- ing five groups: MCD (n ϭ 13), benign NS (n ϭ 16), membranous GATCGCT, antisense ACTTGGAGTTGATGATTTGCGG, internal glomerulopathy (MGN; n ϭ 31), and FSGS (n ϭ 9). For control probe CAACCACATCAAGCTGTCGGGCAG; GLEPP-1: sense biopsies, renal tissue was derived from pretransplantation kidney TCACTGTGGAGATGATTTCAGAGG, antisense CGTCAGCAT- biopsies during cold ischemia time from four cadaveric and four AGTTGATCCGGA, internal probe AGCAGGACGACTGGGCCT- living donors (n ϭ 8). Histologic nonaffected parts of tumor nephrec- GTAGACAC; dystroglycan: sense ACAGGGACCCTGAGAA- tomies